B7-H3 (B7 homolog 3), also known as CD276, serves as a member of the B7-CD28 superfamily18 and is overexpressed in a variety of malignancies, such as CRC, pancreatic cancer, prostate cancer, and ovarian cancer19–22. Here, CD276 is linked to prostate cancer.